Warren Point Capital

WPC invests in targets nearing critical value inflection points, characterized by incremental clearance of preclinical, clinical, regulatory, IP, or commercial risk hurdles. WPC is flexible, acting as lead investor or syndicate member in larger rounds. To our portfolio companies, their management teams, and other investors on the cap table, we operate like a traditional venture firm – vetting, investing, and operating as a single financial sponsor on the cap table. To other stakeholders, we are a different type of venture firm with a unique offering & approach.